• Find us on Facebook
  • Follow BMJ OnExamination on Twitter

News Article Details

ORIGINAL ARTICLE: Oral Anticoagulant and Antiplatelet Therapy and Peripheral...

NEJM - 18/07/2007 21:55:19

In a randomized trial, 2161 patients with peripheral arterial disease were assigned to combination therapy with an antiplatelet agent and an oral anticoagulant or to antiplatelet therapy alone. At a mean follow-up of 35 months, the rate of myocardial infarction, stroke, or death from cardiovascular causes was not significantly different between the two groups. The group receiving combination therapy had a significantly higher rate of life-threatening bleeding.

Members comments

fsj40 - 30/09/2007 09:24:42

using both antiplatlet and anticoagulant is over treatment no need for that

Comment on this article:

Sign in or register to comment on this story


    © 2015 BMJ Publishing Group Ltd . All rights reserved.